je.st
news
Tag: collaboration
PeptiDream Announces Peptide Discovery Collaboration Agreement With Genentech
2016-01-06 06:26:00| drugdiscoveryonline Home Page
PeptiDream Inc., a public Tokyo-based biopharmaceutical company (“PeptiDream”) recently announced a multi-target discovery and optimization collaboration with US-based Genentech Inc., (“Genentech”), a member of the Roche Group
Tags: agreement
collaboration
discovery
announces
Emulate Announces Expanded Collaboration With Merck To Use Organ-Chips In Drug Discovery And Development Process For Inflammatory Diseases
2016-01-06 06:17:13| drugdiscoveryonline Home Page
Emulate Inc. recently announced an expanded research collaboration with Merck, known as MSD outside the United States and Canada, to deploy Emulate’s Organ-Chips across certain Merck discovery programs to improve models of human inflammatory diseases and better predict the potential human response of therapeutic candidates
Tags: development
process
drug
expanded
Oncodesign Biotechnology And Bristol-Myers Squibb Enter Into Strategic Drug Discovery Collaboration
2016-01-06 06:00:34| drugdiscoveryonline Home Page
ONCODESIGN (Alternext – ALONC), a biotechnology company serving the pharmaceutical industry in the discovery of new therapeutic molecules to fight cancer and other serious illnesses with no known effective treatment, recently announced that it has entered into a strategic collaboration agreement with Bristol-Myers Squibb Company to discover, develop and commercialize novel macrocyclic compounds
Tags: enter
drug
collaboration
strategic
Novembers top stories: El Faro debris washes ashore, Sweden and Finland's green collaboration
2015-12-18 13:11:00| Ship Technology
Eleven port operators to bid for Port of Corozal, South Korea eases ban on LPG carrier construction at DSME, Crowley begins construction on terminal expansion project in Puerto Rico. Ship-technology.com wraps up the key headlines from November 2015.
Tags: top
green
stories
sweden
Lilly and Merck Expand Immuno-Oncology Collaboration Adding Abemaciclib and KEYTRUDA (pembrolizumab) Combination Trial
2015-12-10 12:30:08| Merck.com - Product News
Dateline City: INDIANAPOLIS and KENILWORTH, N.J. INDIANAPOLIS and KENILWORTH, N.J. Eli Lilly and Company (NYSE: LLY) and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced another immuno-oncology collaboration that will evaluate abemaciclib (LY2835219), Lillys cyclin-dependent kinase (CDK) 4 and 6 inhibitor, and Mercks KEYTRUDA (pembrolizumab) in a Phase I study across multiple tumor types. Language: English read more
Tags: trial
combination
expand
adding
Sites : [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] next »